H. pylori Eradication Regimen

Patient Assessment and Treatment Approach

The American Gastroenterological Association recommends a 14-day quadruple therapy consisting of pantoprazole, bismuth, clarithromycin, and metronidazole for H. pylori eradication in patients with prior metronidazole and amoxicillin exposure 1, 2, 3
Prior exposure to antibiotics is a critical factor in determining the appropriate H. pylori eradication regimen, as it increases the risk of antibiotic resistance 1, 2
Metronidazole resistance can be overcome with higher doses (1.5-2g daily) and the addition of bismuth 1, 3
The American College of Gastroenterology recommends quadruple therapy for 14 days, including pantoprazole, bismuth, clarithromycin, and metronidazole, for H. pylori eradication in areas with high clarithromycin resistance or after prior antibiotic exposure 4, 3
The 14-day duration is associated with higher eradication rates compared to shorter durations 2, 6

Bismuth-containing quadruple therapy is recommended in areas with high clarithromycin resistance or after prior antibiotic exposure 7
Metronidazole resistance may be overcome with higher doses (1.5-2g daily) and concomitant bismuth therapy 1, 3
Amoxicillin should be dosed at least 2g daily divided TID or QID to avoid low trough levels 2

Confirm eradication with urea breath test or stool antigen test at least 4 weeks after completion of therapy 4, 8
If this regimen fails, consider susceptibility testing to guide further treatment options 2, 6
Alternative regimens for treatment failure include levofloxacin-based triple therapy if available 2, 3